This Solicitation opportunity from Department Of Defense was posted on May 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

LIDOCAINE AND PRILO

Closed

SPE2DP-26-T-3302Federal

Submission Closed05/13/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

PLASMA-LYTE A INJECThe contract involves the procurement of PLASMA-LYTE A INJEC, identified by NSN 6505-01-708-9039, with a total quantity of three units requested under purchase request number 7017120906. The solicitation, designated SPE2DP-26-T-3802, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. The response deadline for the solicitation is June 22, 2026, indicating a brief window for submissions. This contract is categorized as a solicitation with no specified type of set-aside or applicable NAICS code, and the performance location details are not provided. The contracting agency is a federal entity focusing on defense logistics, ensuring the procurement supports government operations. Relevant contract information and updates are accessible via the Defense Logistics Agency's procurement platform.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by the National Stock Number 6505-01-718-3484. The request involves a quantity of five units under purchase request number 7013890090. This solicitation, numbered SPE2DP-26-T-3808, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The procurement is managed by the Defense Logistics Agency, a federal organization within the Department of Defense, and is intended for performance within the United States, although specific locations are not specified. This contract solicitation falls under federal acquisition and does not indicate any set-aside type or NAICS code, implying it may be open to all qualified bidders. The relevant information is accessible through the Defense Logistics Agency’s online portal, where potential vendors can review and respond to the request. Points of contact are not provided in the available data, indicating that interested parties may need to use the online platform for further inquiries.

Defense Logistics Agency

POSTED

DEADLINE

REHYDRATION SALTS FThe contract pertains to the procurement of rehydration salts, specifically identified by the NSN/Part Number 6505-01-731-2277, with a total quantity of 2 units requested under purchase request number 7015714540. The solicitation, titled "REHYRATION SALTS F," was issued by the Defense Logistics Agency, a component of the Department of Defense, on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. This federal solicitation lacks set-aside designations and NAICS code details, indicating it was open to all qualified bidders. The place of performance details were unspecified, suggesting flexibility or further clarification in subsequent communications. The contract focuses on meeting the agency's need for these medical supplies, likely for use in rehydration treatment scenarios, aligning with the Department of Defense's logistical and operational requirements.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by NSN/Part Number 6505-01-718-3478, with a purchase request quantity of five units. This solicitation, numbered SPE2DP-26-T-3803, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The contracting agency responsible for this procurement is the Defense Logistics Agency under the Department of Defense. This contract is a federal solicitation with no set-aside type indicated, and no specific NAICS code was assigned. While the precise location for the place of performance and the office address details are not provided, the procurement is handled within the United States. The contract is publicly available for review on the Defense Logistics Agency’s electronic bidding system, allowing eligible vendors to respond within the designated timeframe.

Defense Logistics Agency

POSTED

DEADLINE

PSYLLIUM HYDROPHILIThe contract pertains to the procurement of Psyllium Hydrophili, identified by the NSN/Part Number 6505-01-719-3181, with a purchase request for a quantity of three units. The solicitation, numbered SPE2DP-26-T-3801, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. It is a federal solicitation, with a response deadline set for June 22, 2026. The contract does not specify any set-aside type or NAICS code, and the exact location details for the office or place of performance are not provided. This solicitation is intended to acquire the specified product through a formal bidding process managed by a federal defense agency. Interested parties are able to access the solicitation and submit their responses through the Defense Logistics Agency’s bidding platform. The contract focuses on ensuring timely procurement within the established deadlines and under federal regulations relevant to government acquisitions.

Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The contract covers the procurement of Lidocaine and Prilocaine periodontal gel, specifically Oraqix, a 2.5%/2.5% microemulsion supplied in dental cartridges containing 1.7 grams of gel. Each cartridge is individually blister-packaged with a sterile, single-use blunt-tipped applicator, and cartons contain 20 cartridges. The item has a total shelf life of 36 months, with at least 31 months remaining upon delivery to the first government activity. Storage conditions require controlled room temperature between 20° to 25°C (68° to 77°F). Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, with appropriate labeling for safe handling and transportation. The contract specifies delivery terms including a 20-day delivery window with FOB destination and zero variance on quantity. Packaging must be commercial-grade, ensuring protection from damage during shipping, and containment is specified according to MIL-STD-2073-1E. The government requires inspection and acceptance at the destination, and adherence to regulatory standards including FDA oversight and hazardous material shipping guidelines. The procurement is managed by the Department of Defense’s Medical Supply Chain Pharmacy FSA, with related contact and technical requirements outlined, and the solicitation is open for response until May 13, 2026.

General Info

Procurement of 2.5% Oraqix gel, 20 cartridges/carton, 36-month shelf life, FOB destination delivery.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers View NAICS

Place of Performance

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3302.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedMay 7

Solicitation

Response DeadlineMay 13

Deadline has passed

Submission Closed

05/13/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

Lawrence Garnett

contact@example.gov

+1 (555) 000-0000

Full Description

LIDOCAINE AND PRILO
LIDOCAINE AND PRILOCAINE, PERIODONTAL GEL.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY. UNIT OF ISSUE IS A PACKAGE CONTAINING 20 CARTRIDGES. ORAQIX
(LIDOCAINE AND PRILOCAINE PERIODONTAL GEL,) 2.5%/2.5% IS A
MICROEMULSION.. ORAQIX (LIDOCAINE AND PRILOCAINE PERIODONTAL GEL),
2.5%/2.5%, IS SUPPLIED IN DENTAL CARTRIDGES THAT PROVIDE 1.7G GEL.
INDIVIDUALLY BLISTER-PACKAGED CARTRIDGES OF ORAQIX ARE DISTRIBUTED IN A
CARTON OF 20.. EACH INDIVIDUAL BLISTER PACKAGE ALSO CONTAINS A STERILE
BLUNT-TIPPED APPLICATOR. EACH BLUNT-TIPPED APPLICATOR IS FOR SINGLE USE
ONLY. TOTAL SHELF LIFE IS 36 MONTHS.. THERE SHALL BE A MINIMUM OF 31
MONTHS OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY THE FIRST
GOVERNMENT ACTIVITY.. STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP
CONTROLLED ROOM TEMPERATURE]. LABELING AND MARKING MUST IN ACCORDANCE
WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013. 08/02/2016
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil.
SPE2DP-26-T-3302
SECTION B
MMS NO. 1 IS ALSO AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
DENTSPLY SIRONA INC 0KSX4 P/N NDC66312-0110-20
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016637619 0001 PG 1.000
NSN/MATERIAL:6505016569640
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
IP025: PACKAGING, MARKING, AND SHIPPING OF HAZARDOUS MATERIALS
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
SPE2DP-26-T-3302
SECTION B
PR: 7016637619 PRLI: 0001 CONT’D
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
FM5270
FM5270 18 MDSS SGSM
CP 011 81 98 938 1111 EXT 634 4572
KADENA AB BLDG 3154
KADENA AB OKINAWA 904 0200
JP
MEDICAL AIR BRIDGE WEST. FOR ELIGIBLE ITEMS: SD0379. CARDINAL HEALTH, 4551 EAST PHILADELPHIA ST ONTARIO,
CA (TEXT IN ENHANCEMENT)
M/F: (TCN) FM527061240267
RDD:
PROJ: TP 3
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:05/07/2026
SPE2DP-26-T-3302 NSN/Part Number: 6505-01-656-9640 Quantity: 1 PG Purchase Request: 7016637619QTY: 1 Delivery: 20 days ADO